Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation.

In obesity, dysregulation of adipocytokines is involved in several pathological conditions including diabetes and certain cancers. As a member of the adipocytokines, adiponectin plays crucial roles in whole-body energy homeostasis. Recently, it has been reported that the level of plasma adiponectin is reduced in several types of cancer patients. However, it is largely unknown whether and how adiponectin affects colon cancer cell growth. Here, we show that adiponectin suppresses the proliferation of colon cancer cells including HCT116, HT29, and LoVo. In colon cancer cells, adiponectin attenuated cell cycle progression at the G(1)/S boundary and concurrently increased expression of cyclin-dependent kinase inhibitors such as p21 and p27. Adiponectin stimulated AMP-activated protein kinase (AMPK) phosphorylation whereas inhibition of AMPK activity blunted the effect of adiponectin on the proliferation of colon cancer cells. Furthermore, knockdown of adiponectin receptors such as AdipoR1 and AdipoR2 relieved the suppressive effect of adiponectin on the growth of colon cancer cells. In addition, adiponectin repressed the expression of sterol regulatory element binding protein-1c, which is a key lipogenic transcription factor associated with colon cancers. These results suggest that adiponectin could inhibit the growth of colon cancer cells through stimulating AMPK activity.

[1]  Pavel Vodicka,et al.  Genetic variation in adipokine genes and risk of colorectal cancer. , 2009, European journal of endocrinology.

[2]  M. C. Archer,et al.  Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis , 2009, International journal of cancer.

[3]  B. Viollet,et al.  AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives , 2009, Acta physiologica.

[4]  E. Erarslan,et al.  Association of Visceral Fat Accumulation and Adiponectin Levels with Colorectal Neoplasia , 2009, Digestive Diseases and Sciences.

[5]  E. Małecka-Panas,et al.  Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients , 2009, International Journal of Colorectal Disease.

[6]  M. Matsuda,et al.  Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice. , 2008, World journal of gastroenterology.

[7]  Nahum Sonenberg,et al.  The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase , 2008, Cancer Prevention Research.

[8]  C. Mantzoros,et al.  Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. , 2008, JAMA.

[9]  Hirokazu Takahashi,et al.  Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition , 2008, Gut.

[10]  H. Ostrer,et al.  Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. , 2008, Cancer research.

[11]  S. Kono,et al.  Adiponectin and colorectal adenomas: Self Defense Forces Health Study , 2008, Cancer science.

[12]  C. Mantzoros,et al.  Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. , 2008, Endocrine-related cancer.

[13]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[14]  Baofeng Yang,et al.  Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. , 2007, Endocrine-related cancer.

[15]  Kohjiro Ueki,et al.  Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. , 2007, Cell metabolism.

[16]  H. Nagawa,et al.  Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2 , 2007, Cancer science.

[17]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[18]  David I. Smith,et al.  Induction of Tumorigenesis and Metastasis by the Murine Orthologue of Tumor Protein D52 , 2007, Molecular Cancer Research.

[19]  A. Xu,et al.  Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. , 2006, Cancer research.

[20]  M. J. Yoon,et al.  Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-Activated Protein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator–Activated Receptor α , 2006, Diabetes.

[21]  Chih-Pin Chuu,et al.  Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. , 2006, Cancer research.

[22]  M. Dieudonné,et al.  Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. , 2006, Biochemical and biophysical research communications.

[23]  M. Hou,et al.  Serum adiponectin and leptin levels in Taiwanese breast cancer patients. , 2006, Cancer letters.

[24]  J. Bub,et al.  Adiponectin as a growth inhibitor in prostate cancer cells. , 2006, Biochemical and biophysical research communications.

[25]  P. Stattin,et al.  Serum Adiponectin is not Associated with Risk of Colorectal Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[26]  Shailendra Giri,et al.  5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside Inhibits Cancer Cell Proliferation in Vitro and in Vivo via AMP-activated Protein Kinase* , 2005, Journal of Biological Chemistry.

[27]  W. Willett,et al.  Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. , 2005, Journal of the National Cancer Institute.

[28]  B. Yu,et al.  Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell , 2005, Archives of pharmacal research.

[29]  K. Çağlar,et al.  Prostate cancer and adiponectin. , 2005, Urology.

[30]  Tadahisa Fukui,et al.  Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance , 2005, Clinical Cancer Research.

[31]  H. Nagawa,et al.  Plasma adiponectin and gastric cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  R. Sinha,et al.  Meat consumption and risk of colorectal cancer. , 2005, JAMA.

[33]  N. Ruderman,et al.  AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms. , 2004, Biochemical and biophysical research communications.

[34]  S. Zolotukhin,et al.  Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[36]  C. Mantzoros,et al.  Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. , 2003, The Journal of clinical endocrinology and metabolism.

[37]  E. Gabrielson,et al.  Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. , 2003, Experimental cell research.

[38]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[39]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[40]  M. Kaminishi,et al.  Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. , 2001, Biochemical and biophysical research communications.

[41]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[42]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Han,et al.  Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. , 2000, Experimental cell research.

[44]  S. Jackowski,et al.  Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells. , 2000, Biochimica et biophysica acta.

[45]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[46]  W. Winder,et al.  Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise. , 1999, Journal of applied physiology.

[47]  D. Hardie,et al.  AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. , 1998, The Biochemical journal.

[48]  B. Spiegelman,et al.  Transcriptional Activation of the Stearoyl-CoA Desaturase 2 Gene by Sterol Regulatory Element-binding Protein/Adipocyte Determination and Differentiation Factor 1* , 1998, The Journal of Biological Chemistry.

[49]  Y. Furuya,et al.  Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis. , 1997, Anticancer research.

[50]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[51]  G. Pasternack,et al.  Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. , 1996, Cancer research.

[52]  G. Pasternack,et al.  Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. , 1996, Cancer research.

[53]  J. Rosenfeld,et al.  Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  P. Visca,et al.  Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients , 1996, Cancer.

[55]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[56]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[57]  I. Fidler,et al.  Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Hirokazu Takahashi,et al.  Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. , 2009, International journal of oncology.

[59]  B. Spiegelman,et al.  Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. , 1998, The Journal of clinical investigation.

[60]  A. Rashid,et al.  Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. , 1997, The American journal of pathology.

[61]  A W Partin,et al.  OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. , 1995, Urology.